Encompass HealthvsMerck & Company

EHC and MRK stock compared: price, dividend, valuation and results, from SEC filings.

EHC

Encompass Health Corporation

$140.41

Value $14.0B

-1.20%
EHC's page

MRK

Merck & Company, Inc.

$143.59

Value $355B

-0.60%
MRK's page

Encompass Health (EHC) has a market value of $14.0B and Merck & Company (MRK) $355B. Over the last year, with dividends, EHC moved +24.7% and MRK +59.1%. The P/E is 21.7 for EHC and 144.7 for MRK. Dividend yield: EHC 0.56%, MRK 2.37%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    EHC$14.0B

    MRK$355B

    MRK is 25 times EHC

  • Revenue, 12 months

    EHC$6.3B

    MRK$67.4B

    MRK is 11 times EHC

  • Net income, 12 months

    EHC$644M

    MRK$2.5B

    MRK is 3.8 times EHC

  • Operating margin

    EHC–

    MRK–

  • ROIC

    EHC16.7%

    MRK3.9%

    12.8 points apart

  • P/E

    EHC21.7

    MRK144.7

    MRK is 6.7 times EHC

  • Dividend yield

    EHC0.6%

    MRK2.4%

    1.8 points apart

  • 5-year return

    EHC+194.2%

    MRK+98.9%

    95.3 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

EHC+194.2%

MRK+98.9%

10020030020222023202420252026
Returns by period
PeriodEHCWith dividendsMRKWith dividends
1 year since November 14, 2025+24.7%Price +23.7%+59.1%Price +54.5%
3 years since November 17, 2023+123.0%+30.6% a yearPrice +118.2%+54.7%+15.6% a yearPrice +41.1%
5 years since November 16, 2021+194.2%+24.1% a yearPrice +180.3%+98.9%+14.7% a yearPrice +70.7%
10 years since November 17, 2016+394.6%+17.3% a yearPrice +331.9%+225.6%+12.5% a yearPrice +140.0%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

EHCEncompass HealthMRKMerck & Company

Valuation

EHCMRK
Valuation
Price$140.41$143.59
Market value$14.0B$355B
Enterprise value (EV)$16.5B$399B
P/E21.7144.7
P/E, 5-year median19.214.8
P/B5.27.9
EV/EBIT15.483.8
Free cash flow yield3.3%4.2%

Results and growth

EHCMRK
Results and growth
Revenue, 12 months$6.3B$67.4B
Net income, 12 months$644M$2.5B
Free cash flow, 12 months$457M$14.7B
Earnings per share, 12 months$6.40$0.98
Revenue growth, year on year10.5%1.3%
Revenue growth a year, past+10.7%over 5 years+9.4%over 5 years
EPS growth a year, past+14.2%over 5 years+21.2%over 5 years

Margins and returns on capital

EHCMRK
Margins and returns on capital
Gross margin–71.8%
Operating margin––
Net margin10.2%3.6%
ROIC16.7%3.9%
ROE25.6%5.2%

Balance sheet

EHCMRK
Balance sheet
Cash$100M$9.7B
Total debt$2.8B$53.8B
Net debt / EBITDA1.85.7
Interest cover8.4×2.4×

Dividends and buybacks

EHCMRK
Dividends and buybacks
Dividend yield0.6%2.4%
Dividend per share, 12 months$0.78$3.40
Dividend growth a year, past-8.5%over 5 years+5.8%over 5 years
Buyback yield1.1%1.4%
Shareholder yield1.7%3.8%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: EHC or MRK

Didn't find what you were looking for?

Ask us
Which is bigger, Encompass Health or Merck & Company?

By market value, Merck & Company ($355B) is about 25.4 times Encompass Health ($14.0B), at today's prices.

How did EHC and MRK stock do over the last 10 years?

Since November 17, 2016, EHC's price moved +331.9% and MRK's +140.0%. With dividends: EHC +394.6% (+17.3% a year), MRK +225.6% (+12.5% a year). Past returns do not predict future ones.

Which pays the higher dividend, EHC or MRK?

The dividend yield at today's price is 0.56% for Encompass Health and 2.37% for Merck & Company. Over the last twelve months they paid $0.78 and $3.40 per share.

What is the P/E of EHC and MRK?

At today's price, the P/E is 21.7 for EHC and 144.7 for MRK. The median of the last five years was 19.2 and 14.8, which shows where each stands against its own past.

Which has the higher profit margins, Encompass Health or Merck & Company?

Over the last twelve months, the net margin was 10.2% for Encompass Health and 3.6% for Merck & Company, and the operating margin – and –. Revenue was $6.3B and $67.4B.

Which is the better investment, Encompass Health or Merck & Company?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.